Literature DB >> 20451601

Genomic phenotype of non-cultured pulmonary fibroblasts in idiopathic pulmonary fibrosis.

Margaret C Emblom-Callahan1, Mantej K Chhina, Oksana A Shlobin, Shahzad Ahmad, Erika S Reese, Eswar P R Iyer, Daniel N Cox, Renee Brenner, Nelson A Burton, Geraldine M Grant, Steven D Nathan.   

Abstract

Activated fibroblasts are the central effector cells of the progressive fibrotic process in idiopathic pulmonary fibrosis (IPF). Characterizing the genomic phenotype of isolated fibroblasts is essential to understanding IPF pathogenesis. Comparing the genomic phenotype of non-cultured pulmonary fibroblasts from advanced IPF patients' and normal lungs revealed novel genes, biological processes and concomitant pathways previously unreported in IPF fibroblasts. We demonstrate altered expression in proteasomal constituents, ubiquitination-mediators, Wnt, apoptosis and vitamin metabolic pathways and cell cycle regulators, suggestive of loss of cellular homeostasis. Specifically, FBXO32, CXCL14, BDKRB1 and NMNAT1 were up-regulated, while RARA and CDKN2D were down-regulated. Paradoxically, pro-apoptotic inducers TNFSF10, BAX and CASP6 were also found to be increased. This comprehensive description of altered gene expression in isolated IPF fibroblasts underscores the complex biological processes characteristic of IPF and may provide a foundation for future research into this devastating disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20451601     DOI: 10.1016/j.ygeno.2010.04.005

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  31 in total

1.  Profibrotic role of miR-154 in pulmonary fibrosis.

Authors:  Jadranka Milosevic; Kusum Pandit; Marcus Magister; Einat Rabinovich; Daniel C Ellwanger; Guoying Yu; Louis J Vuga; Benny Weksler; Panayiotis V Benos; Kevin F Gibson; Michael McMillan; Michael Kahn; Naftali Kaminski
Journal:  Am J Respir Cell Mol Biol       Date:  2012-10-04       Impact factor: 6.914

2.  Essential role of stem cell factor-c-Kit signalling pathway in bleomycin-induced pulmonary fibrosis.

Authors:  Lin Ding; Vladilsav Dolgachev; Zhuang Wu; Tianju Liu; Taku Nakashima; Zhe Wu; Matthew Ullenbruch; Nicholas W Lukacs; Zidi Chen; Sem H Phan
Journal:  J Pathol       Date:  2013-04-03       Impact factor: 7.996

3.  Lung fibroblasts from patients with idiopathic pulmonary fibrosis exhibit genome-wide differences in DNA methylation compared to fibroblasts from nonfibrotic lung.

Authors:  Steven K Huang; Anne M Scruggs; Richard C McEachin; Eric S White; Marc Peters-Golden
Journal:  PLoS One       Date:  2014-09-12       Impact factor: 3.240

4.  Fibrotic extracellular matrix activates a profibrotic positive feedback loop.

Authors:  Matthew W Parker; Daniel Rossi; Mark Peterson; Karen Smith; Kristina Sikström; Eric S White; John E Connett; Craig A Henke; Ola Larsson; Peter B Bitterman
Journal:  J Clin Invest       Date:  2014-03-03       Impact factor: 14.808

5.  Cross-tissue organization of the fibroblast lineage.

Authors:  Matthew B Buechler; Rachana N Pradhan; Akshay T Krishnamurty; Christian Cox; Aslihan Karabacak Calviello; Amber W Wang; Yeqing Angela Yang; Lucinda Tam; Roger Caothien; Merone Roose-Girma; Zora Modrusan; Joseph R Arron; Richard Bourgon; Sören Müller; Shannon J Turley
Journal:  Nature       Date:  2021-05-12       Impact factor: 49.962

6.  Macrophage-derived biomarkers of idiopathic pulmonary fibrosis.

Authors:  E Bargagli; A Prasse; C Olivieri; J Muller-Quernheim; P Rottoli
Journal:  Pulm Med       Date:  2010-11-29

7.  MetaQC: objective quality control and inclusion/exclusion criteria for genomic meta-analysis.

Authors:  Dongwan D Kang; Etienne Sibille; Naftali Kaminski; George C Tseng
Journal:  Nucleic Acids Res       Date:  2011-11-23       Impact factor: 16.971

8.  Molecular Signatures of Idiopathic Pulmonary Fibrosis.

Authors:  Iain R Konigsberg; Raphael Borie; Avram D Walts; Jonathan Cardwell; Mauricio Rojas; Fabian Metzger; Stefanie M Hauck; Tasha E Fingerlin; Ivana V Yang; David A Schwartz
Journal:  Am J Respir Cell Mol Biol       Date:  2021-10       Impact factor: 7.748

Review 9.  Harnessing the ECM Microenvironment to Ameliorate Mesenchymal Stromal Cell-Based Therapy in Chronic Lung Diseases.

Authors:  Linda Elowsson Rendin; Anna Löfdahl; Måns Kadefors; Zackarias Söderlund; Emil Tykesson; Sara Rolandsson Enes; Jenny Wigén; Gunilla Westergren-Thorsson
Journal:  Front Pharmacol       Date:  2021-04-15       Impact factor: 5.810

10.  Bortezomib Inhibits Lung Fibrosis and Fibroblast Activation without Proteasome Inhibition.

Authors:  Loka Raghu Kumar Penke; Jennifer Speth; Scott Wettlaufer; Christina Draijer; Marc Peters-Golden
Journal:  Am J Respir Cell Mol Biol       Date:  2022-01       Impact factor: 7.748

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.